Brainstem Auditory Evoked Potential in HIV-Positive Adults.
BACKGROUND
To characterize the findings of brainstem auditory evoked potential in HIV-positive individuals exposed and not exposed to antiretroviral treatment.


METHODS
This research was a cross-sectional, observational, and descriptive study. Forty-five HIV-positive individuals (18 not exposed and 27 exposed to the antiretroviral treatment - research groups I and II, respectively - and 30 control group individuals) were assessed through brainstem auditory evoked potential.


RESULTS
There were no significant between-group differences regarding wave latencies. A higher percentage of altered brainstem auditory evoked potential was observed in the HIV-positive groups when compared to the control group. The most common alteration was in the low brainstem.


CONCLUSIONS
HIV-positive individuals have a higher percentage of altered brainstem auditory evoked potential that suggests central auditory pathway impairment when compared to HIV-negative individuals. There was no significant difference between individuals exposed and not exposed to antiretroviral treatment.
Department of Physical Therapy, Speech-language Pathology and Audiology, and Occupational Therapy, School of Medicine (FMUSP), University of São Paulo, São Paulo, SP, Brazil.
Carla Gentile
CG
Matas
Department of Physical Therapy, Speech-language Pathology and Audiology, and Occupational Therapy, School of Medicine (FMUSP), University of São Paulo, São Paulo, SP, Brazil.
Alessandra Giannella
AG
Samelli
Department of Physical Therapy, Speech-language Pathology and Audiology, and Occupational Therapy, School of Medicine (FMUSP), University of São Paulo, São Paulo, SP, Brazil.
Rosanna Giaffredo
RG
Angrisani
Department of Physical Therapy, Speech-language Pathology and Audiology, and Occupational Therapy, School of Medicine (FMUSP), University of São Paulo, São Paulo, SP, Brazil.
Fernanda Cristina Leite
FC
Magliaro
Department of Infectious Diseases, School of Medicine (FMUSP), University of São Paulo, São Paulo, SP, Brazil.
Aluísio C
AC
Segurado
D000328:Adult; D044966:Anti-Retroviral Agents / Q000627:therapeutic use; D001301:Audiometry, Pure-Tone; D001933:Brain Stem / Q000473:pathology*; D003430:Cross-Sectional Studies; D016057:Evoked Potentials, Auditory, Brain Stem / Q000502:physiology*; D005260:Female; D015658:HIV Infections / Q000503:physiopathology*; D006679:HIV Seropositivity; D006801:Humans; D008297:Male; D008875:Middle Aged; D011336:Probability; D055815:Young Adult
D044966:Anti-Retroviral Agents